Evidence map›Paper›PMID 41055403›Full record

ArticleJournal of neurotrauma2026

Regeneration after Spinal Cord Injury: A Review on the Crucial Aspects of V2a Interneurons.

Armin Khavandegar, Luke J Bolstad, Amgad S Hanna, Daniel J Hellenbrand

Abstract read
In one paragraph

Article in Journal of neurotrauma, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Armin KhavandegarSina Trauma and Surgery Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Luke J BolstadDepartment of Neurosurgery, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA.
Amgad S HannaDepartment of Neurosurgery, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA.
Daniel J HellenbrandDepartment of Neurosurgery, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA.

Funding

Treating Spinal Cord Injury with Mineral Coated Microparticles Releasing Anti-Inflammatory CytokinesR01NS136564 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI Amgad S Hanna, WILLIAM L. MURPHY · 2024 to 2026
$1.3M
NINDS NIH HHS R01 NS136564
6 · The paper itself

Abstract

Spinal cord injuries (SCI) are extremely difficult to treat due to the limited capacity for neural regeneration across the injury site. However, V2a interneurons have been a point of interest in SCI research over the last decade, as they have been shown to contribute to the promotion of neuroplasticity after injury. These excitatory interneurons contain either long or short projections that are effective at driving rhythmic motor firing. By possessing ipsilateral, contralateral, or propriospinal projections, subtypes of V2a interneurons expressing the visual system homeobox-2 (Vsx-2) gene have been shown to extend their projections past the site of injury and restore injured spinal circuits that contribute to the respiration and right-left coordination. Moreover, Vsx-2/Zfhx3-expressing V2a interneurons in the midthoracic region of the spinal cord are a point of interest due to their unique ability to extend long projections caudally past the injury site and into the lumbar region, which resulted in substantial improvement in hind limb function after SCI in mice. Here, we collectively summarize the origin, subtypes, and the role Vsx-2 V2a interneurons play after SCI. We further describe the various techniques utilized to promote the accumulation and growth of these interneurons across or around the site of injury, effectively rewiring motor networks to contribute to functional recovery.

Indexed as

axonal regenerationcircuit reorganizationinterneuronspinal cord injuryV2aVSX-2

Identifiers

PMID41055403
PMCPMC13587707

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.